SceneDoc Announces Partnership with a Police Department in California

December 14 2017
The Critical Communications Review
Today, SceneDoc announces a partnership with the Ukiah Police Department in California to implement its ‘mobile first’ application for eCitation and reporting. Ukiah is the first agency in the state of California to roll out SceneDoc eCitation, leveraging iPads and iPhones to securely automate their paperwork, collect, manage and share digital evidence, while turning data into actionable intelligence for broader public safety. “When we saw the depth of capabilities offered by the SceneDoc platform, my team and I, along with the city administration, were immediately convinced this software would power a meaningful change. Far too long have police been falling behind with technology adoption, investing in tablets and smartphones is critical for law enforcement in current day. SceneDoc will also extend and compliment the capabilities of our TriTech Inform Records Management System, unleashing new power to our officers,” says Chief of Police, Chris Dewey. (more…) 

MolecuLight technology makes the invisible enemy of wound care, visible to clinicians across the world.

Rachel Cunningham
LONDON–(BUSINESS WIRE)–Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the European launch of MolecuLight i:XTM, the easy to use, handheld imaging device that instantly measures wound surface area and visualises the presence and distribution of potentially harmful bacteria in wounds.2,3 Currently wound assessments are made with the naked eye which can lack the accuracy required to most effectively guide clinical decision making.4 Using fluorescence, MolecuLight i:X quickly, safely, and easily visualises potentially harmful bacteria1,2,3 in wounds which may otherwise lack signs or symptoms of infection. It enhances a clinician’s ability to choose the right therapy, at the right time for their patient1,2 and can help to guide wound sampling and debridement,1,5,6 monitor wound progression,2,3 improve patient engagement4,5 and simplify wound documentation.1 (more…)   

MolecuLight’s Revolutionary Technology Will Help Over 2M People Across Europe

Ian Withers
FTSE 100 medical products firm Smith & Nephew has launched a digital scanner that enables nurses to make an on-the-spot diagnosis as to whether a wound is infected. The handheld device, called MolecuLight, instantly determines whether harmful bacteria are present in a wound. Currently nurses have to send a swab off to a lab for analysis, causing delay in treatment. In clinical trials Smith & Nephew found using the scanner led to 54pc more accurate diagnoses and wounds healing up to nine times faster.

Smith & Nephew hopes sales of the device will boost its wound care division, which accounts for around a quarter of its $4.7bn (£3.5bn) annual revenues. The firm came under pressure last month to improve performance after it emerged activist investor Elliott Advisors had built up a stake and was pushing for the company to be broken up. Read More 

 

SceneDoc partners with New Zealand Police for eNotes proof-of-concept


WELLINGTON, NZ — SceneDoc, public safety’s trusted data collection platform, announces today a partnership with New Zealand Police to undertake a Proof of Concept (PoC) leveraging their commerical-off-the-shelf (COTS) eNotes application. “NZ Police are exploring how we can use our current Police-issued iPhones to allow officers to collect and share their notes digitally,” says Superintendent Rob Cochrane, Director of Mobility and Innovation.  The Proof of Concept will run for a six-week period with a focus on learning and understanding what Police need from a notes application. The findings will inform future decisions for a digital notebook capability in an operational environment. Read More   

Exact Imaging Uses Machine Learning for Semi-Automated Smart Detection of Prostate Cancer

Daniel Rohdbach
Prostate cancer is the second-leading cause of male cancer-related death in the U.S. with approximately 1 in 7 men being diagnosed with prostate cancer during their lifetime[i].  Detection and diagnosis of this significant disease presents a major clinical challenge because the current standard-of-care imaging method, conventional transrectal ultrasound, cannot reliably distinguish cancerous from non-cancerous prostate tissue.  Therefore, prostate biopsies for definitively diagnosing cancer are currently delivered in a systematic but “blind” pattern.  Other imaging methods, such as MRI, have been investigated for guiding biopsies, but MRI involves complicated procedures, is costly, is poorly tolerated by most patients, and  demonstrates significant variability among clinical sites and practitioners.  Read More     

eSight Visit: iGan Analyst tests virtual reality glasses on family member with Stargardt Disease

December 1 2018
Anand Ganeshalingam
It was a cold bright day in November, and the clocks were striking ten. A crowd was bustling through Toronto’s union station, and my uncle, standing next to me, counted the chimes quietly on his fingers. He has Stargardt Disease and can’t see the clock across the room, so he counts the chimes to tell the time. We were on our way to meet with eSight eye-wear, located conveniently close to union station, at Front and University.
(more…)

eSight has been named ‘best invention’ of 2017 by Time Magazine

Alexandra Sifferlin
For the millions of people who are legally blind, navigation is a routine challenge. Though support canes and guide dogs can help, they cannot mimic actual vision. eSight 3 can. Think of it as the world’s most powerful pair of glasses: once users put on eSight, it records high­ definition video and uses magnification, contrast and proprietary algorithms to enhance that imagery into something the legally blind can see—enabling them to partake in a variety of activities, including sports, that would otherwise be off-­limits. At $9,995, the device, which launched in February, is not accessible to everyone (though the company does help connect would-­be buyers with funding sources, including grants). But it is cheaper than the company’s earlier iterations, as well as faster, lighter and equipped with better zoom capabilities. To date, the company estimates it has been used by more than 1,000 patients. —Alexandra Sifferlin Read More     

SceneDoc & Galaxy S8 help Transit Police automate data collection


Samsung public safety solutions address the technology limitations that law enforcement, fire and EMS agencies face daily, incorporating the seamless integration of ubiquitous data access, defense-grade security and intuitive mobile technology that your people need to be agile and stay safe. Read More

Quandl is investors’ secret weapon to beating the market

Claire Brownell
Hedge funds are willing to pay handsomely for Quandl’s alternative data because it helps them achieve alpha, or market-beating returns, that are harder and harder to come by as information becomes easier to find and analyze. (more…)  

Exact Imaging Exec tested companies medical imaging tech – and found out he had cancer

Rajiv Rao
Rob Sandler never thought that his marketing job at Exact Imaging would one day save his life. Read more at MaRS Blog